الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 146 |  |  |
| | | from | 146 | | |
Abstract
Macular translocation seems to be a promising therapeutic option for stabilizing or improving vision in patients with choroidal neovascularization (CNV), compared with orher available treatment modalities for (CNV) (Atsenbrey et all 2,002).Macular translocation is defined by as surgery that has a primary goa] of relocatmg the centra] neurosensory
retina or fovea to IIIl area outside the border ofthe lesion intraoperativelyor post operatively) specifically for management of macular disease.The principle of macuiar translocation is to move the neurosensory retina 111 an eye with recent-onset subfoveal lesion to a new location with presumably healthier retinal. plgmentepithelium lind choriccapillaris away from the lesion. the fovea may be able to recover or maintain its visual function.
Methods of treatments that have been tried to reduce the risk of severe visual loss from exudative age related macular degeneration (AMD) include laser photocoegulation, photodynamic therapy and surgical removal of choroidal neovascularization (CNV).
In all these methods of treatment. the underlying retinal pigment epithelium (RPE) is damaged from either the disease process or the method of treatment (Art Bong et al., 200.!).
The high and increasing preva ence of subfovealchoroidal neovascularization, the absence of a treatment that could eirberimprove or maintain visual acuity in the majority of patients. and the small number of patients who lire eligible for laser treatment have prompted the